© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
Majority of Pregnant Patients Accepted RSV Protection in Vaccine's First Season
May 16, 2025
Two-thirds of pregnant individuals opted for either maternal vaccination against RSV or for neonatal monoclonal antibody therapy and for other vaccines recommended in pregnancy.
Low Uptake of Hereditary Cancer Screening Among Breast Cancer Survivors Highlights Missed Opportunities for Preventive Care
May 16, 2025
In a cancer survivorship clinic in urban New York, only one-quarter of long-term breast cancer survivors received genetic testing, contrary to current recommendations.
For Recurrent Bacterial Vaginosis, Simplified Once-Weekly Treatment Found More Effective than CDC-Recommended Regimen
May 16, 2025
Secnidazole granules reduced recurrence rates to 20% over a period of 28 weeks in a small prospective pilot study, outperforming cumbersome daily regimens.
Cannabis-Related ED Visits May Raise Dementia Risk: Daily Dose
May 16, 2025
Your daily dose of the clinical news you may have missed.
Oral Gepotidacin Rivals Standard Gonorrhea Regimen in Trial: Daily Dose
May 15, 2025
Your daily dose of the clinical news you may have missed.
Atopic Dermatitis Treatment Caution: Long-Term Oral Corticosteroid Use Ups Cardiovascular and Thrombotic Risks
May 14, 2025
The potential cardiovascular impact of prolonged oral corticosteroid therapy in the AD population observed in this study confirms longstanding cautions.
Semaglutide Linked to Reduced Risk for MACE Months Before Weight Loss Begins: Post Hoc Analysis
May 14, 2025
Semaglutide was associated with a significant reduction in risk for major adverse cardiovascular events after just 3 months of treatment in a population with established CVD.
Bone Loss Slowed in Women on Med Diet, Exercise Plan: Daily Dose
May 14, 2025
Your daily dose of the clinical news you may have missed.
Managing Vasomotor Symptoms of Menopause: A Topline Comparison of Treatments
May 13, 2025
Medical and nonpharmacologic treatment options for VMS range in efficacy and risk/benefit profile; a short slide show offers a topline look at how many compare.
A Half Dose of Semaglutide Yields Weight Loss Equivalent to Clinical Trial Doses in Combination with Online Support Program
May 13, 2025
Semaglutide dosing was individually tailored for adults with obesity and supported with app-based coaching on diet, physical activity, and other lifestyle factors.